Oscar Health, Inc.
OSCRNYSE
$29.10
↑ +0.8%Jul 17 close · end-of-day
Price
1Y↑ +89.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$9.6B
Enterprise Value
$3.2B
P/E
—
P/S
0.7
P/B
5.8
EV/EBITDA
81.1
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$13.3B
Net Income (TTM)
-$39.4M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
0.1%
Net Margin
-0.3%
ROE
-2.4%
ROIC
—
Debt / Equity
0.3
Net Cash
$6.4B
Return 1Y
+109.8%
Company profile
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans. +Oscar is a technology driven platform designed to help providers and payor clients to engage with members and patients.
- CEO
- Mario T. Schlosser
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Insurance
- Employees
- 2,710
- Headquarters
- New York
- Website
- hioscar.com
Management & directors
- Bertolini Mark TChief Executive Officer
- Baltrus VictoriaChief Accounting Officer
- Blackley Richard ScottChief Financial Officer
- Liang JanetPresident, Oscar Insurance
- Mcananey AdamChief Legal Officer
- Schlosser MarioPresident of Technology & CTO
Roles derived from SEC Form 4 filings.
Earnings
OSCR Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$4.6B↑ +52.6%
Diluted EPS$2.07↑ +125.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $462.8M | $1.8B | $4.0B | $5.9B | $9.2B | $11.7B |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$402.3M | -$544.5M | -$589.9M | -$235.6M | $57.3M | -$396.4M |
| Net income | -$406.8M | -$572.6M | -$606.3M | -$270.7M | $25.4M | -$443.2M |
| Diluted EPS | -$14.16 | -$3.20 | -$2.85 | -$1.22 | $0.10 | -$1.69 |
| Operating cash flow | $222.7M | -$181.7M | $380.3M | -$272.2M | $978.2M | $1.1B |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -86.9% | -29.6% | -14.9% | -4.0% | 0.6% | -3.4% |
| Net margin | -87.9% | -31.1% | -15.3% | -4.6% | 0.3% | -3.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.4B | $2.4B | $3.0B | $2.9B | $3.0B | $2.8B | $4.6B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $67.8M | -$48.4M | -$147.7M | $297.1M | -$230.5M | -$129.3M | -$333.7M | $704.1M |
| Net income | $56.2M | -$54.6M | -$153.5M | $275.3M | -$228.4M | -$137.4M | -$352.6M | $679.0M |
| Diluted EPS | $0.20 | -$0.22 | -$0.50 | $0.92 | -$0.89 | -$0.53 | -$1.19 | $2.07 |
| Operating cash flow | $497.2M | -$500.1M | $346.8M | $878.5M | $509.1M | -$964.7M | $671.9M | $2.6B |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 3.1% | -2.0% | -6.2% | 9.8% | -8.0% | -4.3% | -11.9% | 15.2% |
| Net margin | 2.5% | -2.3% | -6.4% | 9.0% | -8.0% | -4.6% | -12.6% | 14.6% |
Company news
Jul 17, 2026
Jul 16, 2026
- 4d agoWhy Fast-paced Mover Oscar Health (OSCR) Is a Great Choice for Value Investorsfinance.yahoo.com
- 4d ago1 Russell 2000 Stock to Own for Decades and 2 We Avoidfinance.yahoo.com
- 4d agoZacks Industry Outlook Highlights Oscar Health, Radian, CNO Financial, Pelagos Insurance Capital and Horace Mann Educatorsfinance.yahoo.com
Jul 15, 2026
Jul 14, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Schlosser Mario | Sale | 30,228 | $31.65 | $956,716.20 | filing |
| 2026-07-01 | Schlosser Mario | Sale | 13,672 | $30.80 | $421,097.60 | filing |
| 2026-07-01 | Schlosser Mario | Sale | 3,600 | $29.50 | $106,200.00 | filing |
| 2026-07-01 | Schlosser Mario | C | 47,500 | — | — | filing |
| 2026-06-30 | Bertolini Mark T· Chief Executive Officer | Sale | 488,654 | $28.35 | $13.9M | filing |
| 2026-06-30 | Bertolini Mark T· Chief Executive Officer | Sale | 135,590 | $28.97 | $3.9M | filing |
| 2026-06-29 | Bertolini Mark T· Chief Executive Officer | Sale | 555,826 | $29.17 | $16.2M | filing |
| 2026-06-29 | Bertolini Mark T· Chief Executive Officer | Sale | 58,926 | $30.08 | $1.8M | filing |
| 2026-06-26 | Bertolini Mark T· Chief Executive Officer | Sale | 441,373 | $29.11 | $12.8M | filing |
| 2026-06-26 | Bertolini Mark T· Chief Executive Officer | Sale | 149,795 | $29.79 | $4.5M | filing |
| 2026-06-25 | Bertolini Mark T· Chief Executive Officer | Sale | 597,942 | $28.60 | $17.1M | filing |
| 2026-06-25 | Bertolini Mark T· Chief Executive Officer | Sale | 17,200 | $29.08 | $500,176.00 | filing |
| 2026-06-23 | Schlosser Mario | Sale | 591,213 | $29.58 | $17.5M | filing |
| 2026-06-23 | Schlosser Mario | Sale | 286,988 | $28.95 | $8.3M | filing |
| 2026-06-23 | Schlosser Mario | Sale | 33,592 | $29.58 | $993,651.36 | filing |
| 2026-06-23 | Schlosser Mario | Sale | 33,591 | $29.58 | $993,621.78 | filing |
| 2026-06-23 | Schlosser Mario | Sale | 31,912 | $29.58 | $943,956.96 | filing |
| 2026-06-23 | Schlosser Mario | Sale | 16,307 | $28.95 | $472,087.65 | filing |
| 2026-06-23 | Schlosser Mario | Sale | 16,306 | $28.95 | $472,058.70 | filing |
| 2026-06-23 | Schlosser Mario | Sale | 15,491 | $28.95 | $448,464.45 | filing |
| 2026-06-23 | Schlosser Mario | Sale | 1,799 | $30.09 | $54,131.91 | filing |
| 2026-06-23 | Schlosser Mario | Sale | 102 | $30.09 | $3,069.18 | filing |
| 2026-06-23 | Schlosser Mario | Sale | 102 | $30.09 | $3,069.18 | filing |
| 2026-06-23 | Schlosser Mario | Sale | 97 | $30.09 | $2,918.73 | filing |
| 2026-06-23 | Schlosser Mario | C | 47,500 | — | — | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.